Revolution Medicines Inc. Common Stock vs Ventas Inc. Common Stock — how do they compare? Revolution Medicines Inc. Common Stock trades at $189 (market cap $43.07B), while Ventas Inc. Common Stock trades at $80.12 (market cap $41.06B). The key difference: Revolution Medicines Inc. Common Stock and Ventas Inc. Common Stock are close in size by market cap, and Ventas Inc. Common Stock pays a 2.6% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and Ventas Inc. Common Stock for 0 Days on average.
| RVMD | VTR | |
|---|---|---|
Market Cap | $43.07B | $41.06B |
Volume | 1,184,841 | 4,174,820 |
Sector | Health | Real Estate |
52-Week High | $221.15 | $100.53 |
52-Week Low | $47.50 | $67.45 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $39.77B | $53.78B |
Dividend Yield | — | 2.6% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →Ventas is a real estate investment trust focused on healthcare properties. Its portfolio includes senior housing, medical office buildings, and research-related facilities.
Read more on VTR →